Insulet (PODD)

• Market cap: $9.9B
• 1 day: 0.18%
• 5 days: -7.53%
• 1 month: -10.69%
• 3 months: -41.78%
• 6 months: -54.02%
• Year to date: -49.49%
• 1 year: -55.87%
• 5 years: -45.96%
• 10 years: 376.05%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 5,400